Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146573896> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2146573896 endingPage "222" @default.
- W2146573896 startingPage "211" @default.
- W2146573896 abstract "Adoptive immunotherapy is considered a promising strategy for the treatment of metastatic tumors and current research efforts are directed to define the optimal approach and facilitate the transferability from preclinical to clinical settings. Among several approaches it is possible to schematically distinguish strategies based on either MHC-restricted or MHC-unrestricted immune effectors. The first are mainly based on the infusion of tumor-specific T lymphocytes capable of recognizing determined MHC-restricted tumor associated antigens (TAA) through their T cell receptor. MHC-unrestricted approaches do not target specific tumor associated antigens and are mainly mediated by effectors of the innate immune system, like natural killer (NK) cells or NKT cells, first barrier against pathogens and tumorigenesis processes, or by ex vivo activated lymphocytes like cytokine-induced killer (CIK) cells. MHC-unrestricted effectors are usually more abundant than TAA-specific precursors and easier to expand. Furthermore their activity is not restricted to precise HLAhaplotypes, not limited to a single tumor histotype and could overcome downregulation of MHC molecules operated by tumor cells as immune escape mechanism. In this review we will discuss the main cancer immunotherapy strategies based on MHC-unrestricted immune effectors. The topic will be approached from the angle of ex vivo expansion protocols in clinical prospective, as well as potential approaches to favorably modulate their functions. Keywords: Adoptive immunotherapy, MHC-unrestricted activity, NK, CIK, NKT." @default.
- W2146573896 created "2016-06-24" @default.
- W2146573896 creator A5018953431 @default.
- W2146573896 creator A5032966282 @default.
- W2146573896 creator A5041240875 @default.
- W2146573896 creator A5051114812 @default.
- W2146573896 creator A5056702454 @default.
- W2146573896 creator A5072883486 @default.
- W2146573896 creator A5083581324 @default.
- W2146573896 creator A5086890383 @default.
- W2146573896 date "2014-01-31" @default.
- W2146573896 modified "2023-09-23" @default.
- W2146573896 title "Ex Vivo-Activated MHC-Unrestricted Immune Effectors for Cancer Adoptive Immunotherapy" @default.
- W2146573896 doi "https://doi.org/10.2174/18715206113136660371" @default.
- W2146573896 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24237224" @default.
- W2146573896 hasPublicationYear "2014" @default.
- W2146573896 type Work @default.
- W2146573896 sameAs 2146573896 @default.
- W2146573896 citedByCount "3" @default.
- W2146573896 countsByYear W21465738962014 @default.
- W2146573896 countsByYear W21465738962016 @default.
- W2146573896 countsByYear W21465738962019 @default.
- W2146573896 crossrefType "journal-article" @default.
- W2146573896 hasAuthorship W2146573896A5018953431 @default.
- W2146573896 hasAuthorship W2146573896A5032966282 @default.
- W2146573896 hasAuthorship W2146573896A5041240875 @default.
- W2146573896 hasAuthorship W2146573896A5051114812 @default.
- W2146573896 hasAuthorship W2146573896A5056702454 @default.
- W2146573896 hasAuthorship W2146573896A5072883486 @default.
- W2146573896 hasAuthorship W2146573896A5083581324 @default.
- W2146573896 hasAuthorship W2146573896A5086890383 @default.
- W2146573896 hasBestOaLocation W21465738962 @default.
- W2146573896 hasConcept C147483822 @default.
- W2146573896 hasConcept C150903083 @default.
- W2146573896 hasConcept C170627219 @default.
- W2146573896 hasConcept C203014093 @default.
- W2146573896 hasConcept C207001950 @default.
- W2146573896 hasConcept C207936829 @default.
- W2146573896 hasConcept C26291073 @default.
- W2146573896 hasConcept C2776090121 @default.
- W2146573896 hasConcept C2777701055 @default.
- W2146573896 hasConcept C2780674031 @default.
- W2146573896 hasConcept C502942594 @default.
- W2146573896 hasConcept C51785407 @default.
- W2146573896 hasConcept C86803240 @default.
- W2146573896 hasConcept C8891405 @default.
- W2146573896 hasConcept C90375314 @default.
- W2146573896 hasConceptScore W2146573896C147483822 @default.
- W2146573896 hasConceptScore W2146573896C150903083 @default.
- W2146573896 hasConceptScore W2146573896C170627219 @default.
- W2146573896 hasConceptScore W2146573896C203014093 @default.
- W2146573896 hasConceptScore W2146573896C207001950 @default.
- W2146573896 hasConceptScore W2146573896C207936829 @default.
- W2146573896 hasConceptScore W2146573896C26291073 @default.
- W2146573896 hasConceptScore W2146573896C2776090121 @default.
- W2146573896 hasConceptScore W2146573896C2777701055 @default.
- W2146573896 hasConceptScore W2146573896C2780674031 @default.
- W2146573896 hasConceptScore W2146573896C502942594 @default.
- W2146573896 hasConceptScore W2146573896C51785407 @default.
- W2146573896 hasConceptScore W2146573896C86803240 @default.
- W2146573896 hasConceptScore W2146573896C8891405 @default.
- W2146573896 hasConceptScore W2146573896C90375314 @default.
- W2146573896 hasIssue "2" @default.
- W2146573896 hasLocation W21465738961 @default.
- W2146573896 hasLocation W21465738962 @default.
- W2146573896 hasLocation W21465738963 @default.
- W2146573896 hasOpenAccess W2146573896 @default.
- W2146573896 hasPrimaryLocation W21465738961 @default.
- W2146573896 hasRelatedWork W2035649284 @default.
- W2146573896 hasRelatedWork W2038028318 @default.
- W2146573896 hasRelatedWork W2070030959 @default.
- W2146573896 hasRelatedWork W2111140175 @default.
- W2146573896 hasRelatedWork W2114785263 @default.
- W2146573896 hasRelatedWork W2161871188 @default.
- W2146573896 hasRelatedWork W2527629689 @default.
- W2146573896 hasRelatedWork W2953447703 @default.
- W2146573896 hasRelatedWork W3194933657 @default.
- W2146573896 hasRelatedWork W4295214918 @default.
- W2146573896 hasVolume "14" @default.
- W2146573896 isParatext "false" @default.
- W2146573896 isRetracted "false" @default.
- W2146573896 magId "2146573896" @default.
- W2146573896 workType "article" @default.